Facultad de Veterinaria
Zentro akademikoa
Centro Nacional de Investigaciones Cardiovasculares Carlos III
Madrid, EspañaCentro Nacional de Investigaciones Cardiovasculares Carlos III-ko ikertzaileekin lankidetzan egindako argitalpenak (7)
2023
-
Silencing of microRNA-106b-5p prevents doxorubicin-mediated cardiotoxicity through modulation of the PR55α/YY1/sST2 signaling axis
Molecular Therapy - Nucleic Acids, Vol. 32, pp. 704-720
2022
-
Deciphering the Role and Signaling Pathways of PKCα in Luminal A Breast Cancer Cells
International Journal of Molecular Sciences, Vol. 23, Núm. 22
2021
-
The miRNA199a/SIRT1/P300/Yy1/sST2 signaling axis regulates adverse cardiac remodeling following MI
Scientific Reports, Vol. 11, Núm. 1
2020
-
Author Correction: Empagliflozin improves post-infarction cardiac remodeling through GTP enzyme cyclohydrolase 1 and irrespective of diabetes status (Scientific Reports, (2020), 10, 1, (13553), 10.1038/s41598-020-70454-8)
Scientific Reports
-
Empagliflozin improves post-infarction cardiac remodeling through GTP enzyme cyclohydrolase 1 and irrespective of diabetes status
Scientific Reports, Vol. 10, Núm. 1
2019
-
Effective cancer immunotherapy by natural mouse conventional type-1 dendritic cells bearing dead tumor antigen
Journal for ImmunoTherapy of Cancer, Vol. 7, Núm. 1
-
Generation and characterization of a novel knockin minipig model of Hutchinson-Gilford progeria syndrome
Cell Discovery, Vol. 5, Núm. 1